Leflunomide

In the US, Leflunomide (leflunomide systemic) is a member of the following drug classes: antirheumatics, selective immunosuppressants and is used to treat Rheumatoid Arthritis.

US matches:

• Leflunomide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA13

CAS registry number (Chemical Abstracts Service)

0075706-12-6

Chemical Formula

C12-H9-F3-N2-O2

Molecular Weight

270

Therapeutic Categories

Selective immunosuppressant

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Chemical Name

4-Isoxazolecarboxamide, 5-methyl-N-(4-trifluoromethyl)phenyl)-

Foreign Names

• Leflunomidum (Latin)
• Leflunomid (German)
• Léflunomide (French)
• Leflunomida (Spanish)

Generic Names

• Leflunomide (OS: USAN, BAN)
• Léflunomide (OS: DCF)
• HWA 486 (IS: HoechstMarion)
• RS 34821 (IS: HoechstMarion)
• SU 101 (IS: Sugen)
• Leflunomide (PH: Ph. Eur. 6, BP 2010, USP 32)
• Leflunomidum (PH: Ph. Eur. 6)

Brand Names

• Afiancen
  Buxton, Argentina



• AFT Leflunomide
  AFT, New Zealand



• Apo-Leflunomide
  Apotex, Canada



• Arabloc
  Sanofi-Aventis, Australia



• Arava
  Aventis, Bosnia & Herzegowina; Aventis, Bulgaria; Aventis, Czech Republic; Aventis, France; Aventis, India; Aventis, Iceland; Aventis, Serbia; Aventis, Slovakia; Aventis, South Africa; Sanofi Aventis, Japan; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Luxembourg; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Oman; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, Romania; Sanofi-Aventis, Russian Federation; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Thailand; Sanofi-Aventis, Tunisia; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Aventis, Venezuela; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain; Usiphar, Slovenia



• Aravida
  Farmindustria, Peru



• Arheuma
  Lotus, Taiwan



• Arolef
  General Pharma, Bangladesh



• Artrimod
  Labomed, Chile



• Artrotin
  Recalcine, Chile



• Filartros
  Ivax, Argentina; Medco, Peru



• Inmunoartro
  Beta, Argentina



• Lefluar
  Rontag, Argentina



• Leflumide
  AC Farma, Peru



• Leflunomida
  Caferma, Peru; Spedrog-Caillon, Argentina



• Leflunomide
  Apotex, United States; Heritage, United States; Par, United States; Prasco, United States; Sandoz, United States; Teva USA, United States



• Lefra
  Torrent, Myanmar; Torrent, Vietnam



• Lera
  Globe, Bangladesh



• Nodia
  Incepta, Bangladesh



• PMS-Leflunomide
  Pharmascience, Canada



• Redupar
  Medis, Tunisia



• Rumalef
  Cadila Gehört zu Zydus, India



• Sandoz Leflunomide
  Sandoz, Canada

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.